257 publications
Zinnige Zorg in-depth phase report appropriate post-treatment surveillance of patients with non-melanoma skin cancer or actinic keratosis
As part of the Zinnige Zorg programme, Zorginstituut Nederland started the in-depth phase of appropriate post-treatment ...
Package advice in practice - Deliberations for arriving at a fair package
The public debate pays a lot of attention to how we can continue to pay for health care in the future. A question that the ...
Semaglutide (Ozempic®) for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise
Zorginstituut Nederland carried out a marginal assessment of whether semaglutide (Ozempic®) is interchangeable with a drug ...
Working method for the Zinnige Zorg (appropriate care) Programme
Zorginstituut Nederland’s motto is "Taking care of good health care: no more and no less than necessary". Every citizen must be ...
Zinnige Zorg implementation of the appropriate care of expensive drugs in cases of castration-refractory prostate cancer (CRPC)
This letter is to inform the Minister of Medical Care and Sport about the changes made by parties during the implementation phase ...
Hydrocortisone sodium phosphate (Softacor®) for the treatment of mild non-infectious allergic or inflammatory conjunctival diseases
Zorginstituut Nederland has carried out an assessment of the medicinal product hydrocortisone sodium phosphate (Softacor®) can be ...
Zinnige Zorg room for improvement analysis: Peripheral Arterial Disease
This Room for Improvement Analysis describes the research and the resulting actions and agreements that focus on further ...
Roflumilast (Daxas®) for maintenance treatment of severe chronic obstructive lung disease (COPD)
Zorginstituut Nederland has carried out an assessment of whether roflumilast (Daxas®) is interchangeable with a drug currently ...
SGLT2 inhibitors for the treatment of type 2 diabetes: relaxing List 2 conditions
Zorginstituut Nederland has carried out a substantive assessment of whether the existing list 2 conditions for SGLT2 inhibitors ...
Teduglutide (Revestive®) for the treatment of short bowel syndrome
The Minister of Health, Welfare and Sport (VWS) has asked Zorginstituut Nederland to carry out an assessment of teduglutide ...